Deutsch English Français

Contact

EP0808838

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0808838

EP0808838 - Sulfur-containing heterocyclic bradykinin antagonists, processes for their production and use thereof [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 27.08.2004 Database last updated on 25.09.2024
Most recent event Tooltip	11.01.2008	Lapse of the patent in a contracting state New state(s): PT	published on 13.02.2008 [2008/07]
Applicant(s)	For all designated states HOECHST AKTIENGESELLSCHAFT Brüningstrasse 50 65929 Frankfurt am Main / DE
	[2003/43]
Former [1997/48]	For all designated states HOECHST AKTIENGESELLSCHAFT Brüningstrasse 50 65929 Frankfurt am Main / DE
Inventor(s)	01 / Wagner, Adalbert, Dr. Hans-Fischer-Strasse 4 86368 Gersthofen / DE
	02 / Heitsch, Holger, Dr. Castellumstrasse 52 55252 Mainz-Kastel / DE
	03 / Nölken, Gerhard, Dr. Starkeradweg 15 65843 Sulzbach / DE
	04 / Wirth, Klaus, Dr. Robert-Schumann-Ring 104 65830 Kriftel / DE
	05 / Schölkens, Bernward, Prof. Dr. Hölderlinstrasse 62 65779 Kelkheim / DE
	[1997/48]
Application number, filing date	97107623.7	09.05.1997
	[1997/48]
Priority number, date	DE1996120508	22.05.1996 Original published format: DE 19620508
	[1997/48]
Filing language	DE
Procedural language	DE
Publication	Type:	A1 Application with search report
	No.:	EP0808838
	Date:	26.11.1997
	Language:	DE
	[1997/48]
	Type:	B1 Patent specification
	No.:	EP0808838
	Date:	22.10.2003
	Language:	DE
	[2003/43]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	30.07.1997
Classification	IPC:	C07D277/62, C07D417/12, A61K31/41	[1997/48]
	CPC data not yet available
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/48]
Extension states	SI	09.06.1997
Title	German:	Schwefel enthaltende heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung	[1997/48]
	English:	Sulfur-containing heterocyclic bradykinin antagonists, processes for their production and use thereof	[1997/48]
	French:	Antagonistes de bradykinine soufrés, procédé pour leur préparation et leur utilisation	[1997/48]
Examination procedure	26.05.1998	Examination requested [1998/30]
	11.06.2001	Despatch of a communication from the examining division (Time limit: M04)
	19.10.2001	Reply to a communication from the examining division
	15.11.2002	Despatch of a communication from the examining division (Time limit: M04)
	19.02.2003	Reply to a communication from the examining division
	10.04.2003	Communication of intention to grant the patent
	20.08.2003	Fee for grant paid
	20.08.2003	Fee for publishing/printing paid
Opposition(s)	23.07.2004	No opposition filed within time limit [2004/42]
Fees paid	Renewal fee
	31.05.1999	Renewal fee patent year 03
	31.05.2000	Renewal fee patent year 04
	31.05.2001	Renewal fee patent year 05
	31.05.2002	Renewal fee patent year 06
	02.06.2003	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	FI	22.10.2003
	IE	22.10.2003
	DK	22.01.2004
	GR	22.01.2004
	SE	22.01.2004
	PT	22.03.2004
	AT	09.05.2004
	LU	09.05.2004
	BE	31.05.2004
	CH	31.05.2004
	LI	31.05.2004
	[2008/07]
Former [2005/51]	FI	22.10.2003
	IE	22.10.2003
	DK	22.01.2004
	GR	22.01.2004
	SE	22.01.2004
	AT	09.05.2004
	LU	09.05.2004
	BE	31.05.2004
	CH	31.05.2004
	LI	31.05.2004
Former [2005/28]	FI	22.10.2003
	IE	22.10.2003
	DK	22.01.2004
	GR	22.01.2004
	SE	22.01.2004
	LU	09.05.2004
	BE	31.05.2004
	CH	31.05.2004
	LI	31.05.2004
Former [2005/23]	FI	22.10.2003
	IE	22.10.2003
	DK	22.01.2004
	GR	22.01.2004
	SE	22.01.2004
	LU	09.05.2004
	CH	31.05.2004
	LI	31.05.2004
Former [2005/21]	FI	22.10.2003
	IE	22.10.2003
	DK	22.01.2004
	GR	22.01.2004
	SE	22.01.2004
	CH	31.05.2004
	LI	31.05.2004
Former [2004/41]	FI	22.10.2003
	IE	22.10.2003
	DK	22.01.2004
	GR	22.01.2004
	SE	22.01.2004
Former [2004/40]	FI	22.10.2003
	IE	22.10.2003
	GR	22.01.2004
	SE	22.01.2004
Former [2004/33]	FI	22.10.2003
	GR	22.01.2004
	SE	22.01.2004
Former [2004/26]	FI	22.10.2003
	SE	22.01.2004
Former [2004/24]	SE	22.01.2004
Documents cited:	Search	[Y]EP0299457 (WARNER LAMBERT CO [US]) [Y] 1-6 * claims 1-7 *;
		[Y]US4863923 (HO PETER P K [US], et al) [Y] 1-6* claims 1-14 *;
		[Y]EP0596406 (FUJISAWA PHARMACEUTICAL CO [JP]) [Y] 1-6 * claims 1-6,8-11 *;
		[Y]WO9506469 (CANCER RES CAMPAIGN TECH [GB], et al) [Y] 1-6 * claims 1-20 *;
		[Y]EP0707852 (LILLY CO ELI [US]) [Y] 1-6 * claims 1-5 *;
		[Y]WO9612491 (LILLY CO ELI [US]) [Y] 1-6 * claims 1-8 *;
		[Y]WO9613485 (FUJISAWA PHARMACEUTICAL CO [JP], et al) [Y] 1-6 * claims 1-10 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p